Robert J. Israel, Senior VP Medical Affairs at PROGENICS PHARMACEUTICALS INC (PGNX), sold 154 shares at $6.33 ($975) on 2011-09-01, disclosed to the SEC on 2011-09-06.
Scheduled sale ($975) by Senior VP Medical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PGNX | SELL | 2015-03-13 | $14K | — | Filing → |
| PGNX | SELL | 2015-03-04 | $32K | — | Filing → |
| PGNX | SELL | 2015-01-13 | $14K | — | Filing → |